Valuation: Asahi Kasei Corporation

Market Cap 2,254B 14.24B 12.65B 11.85B 10.73B 20.23B 1,373B 20.4B 141B 55.21B 701B 53.48B 52.33B P/E 2027 *
13.2x
P/E 2028 * 12.2x
Enterprise Value 2,908B 18.37B 16.32B 15.29B 13.85B 26.1B 1,771B 26.32B 182B 71.23B 905B 69B 67.52B EV / Sales 2027 *
0.89x
EV / Sales 2028 * 0.84x
Free-Float
96.37%
Yield 2027 *
2.71%
Yield 2028 * 2.95%
10-01 Teijin Frontier, Asahi Kasei Advance Merge to Form TA Frontier MT
09-30 Teijin Frontier Co., Ltd. concluded a basic agreement to acquire Asahi Kasei Advance Corporation from Asahi Kasei Corporation. CI
09-15 Asahi Kasei Bioprocess Unveils Vantij Su-Vfc Benchtop for Automated Single-Use Virus Filtration CI
09-14 Asahi Kasei Unit Starts Phase Two Study of Antifungal Cresemba for Pediatric Patients in Japan MT
08-26 Asahi Kasei Unveils New Wet-Process Separator Coating Line in North Carolina, Advancing the Company?s 40-Year North American Battery Separator Strategy CI
08-20 Asahi Kasei Develops Novel Lithium Pre-Doping Technology For Silicon-Rich Lithium-Ion Batteries CI
08-19 Asahi Kasei Expands Capacity For Water Electrolysis And Chlor-Alkali Equipment In Kawasaki CI
08-17 Tranche Update on Asahi Kasei Corporation's Equity Buyback Plan announced on November 5, 2025. CI
08-12 Asahi Kasei Corporation's Equity Buyback announced on November 5, 2025, has closed with 22,859,400 shares, representing 1.69% for ¥39,999.9 million. CI
08-06 Asahi Kasei Corporation and Highchem Shanghai Enter First License Agreement for Production and Sale of Acetolyte Novel Electrolyte in China CI
07-31 Asahi Kasei's Attributable Net Income Surges 173% in Fiscal Q1 MT
07-31 Asahi Kasei Corporation Provides Dividend Guidance for the End of Second Quarter of Fiscal Year Ending March 31, 2027 CI
07-31 Asahi Kasei Corporation Provides Consolidated Earnings Guidance for the Six Months and Fiscal Year Ending March 31, 2027 CI
1 day+0.56%
1 week+1.29%
Current month+0.51%
1 month+2.07%
3 months-4.32%
6 months+8.00%
Current year+19.30%
1 week 20.56
Extreme 20.556
21.39
1 month 19.66
Extreme 19.6554
21.61
Current year 17.63
Extreme 17.63
24.12
1 year 15.18
Extreme 15.18
24.12
3 years 11.86
Extreme 11.86
24.12
5 years 11.8
Extreme 11.8
24.12
10 years 10.69
Extreme 10.69
31
Manager TitleAgeSince
Director of Finance/CFO - -
President 67 31/03/2022
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 71 31/03/2022
Director/Board Member 79 31/05/2018
Director/Board Member 67 31/05/2021
Change 5-day change 1-year change 3-year change Capi.($)
+0.56%+1.29% - - 14.03B
+1.66%+8.72%+25.64%+47.41% 73.19B
+1.67%+1.59%+15.38%+23.55% 48.48B
+2.20%+1.16%+2.07%+25.19% 15.72B
+1.67%+1.98%+44.06%+83.69% 14.03B
+0.55%+1.64%+41.18%+32.54% 10.09B
+2.56%+2.11%+14.23%-14.52% 9.6B
+0.32%+0.06%+17.50% - 9.06B
+1.13%+1.20%+118.33%-2.87% 8.85B
+0.49%-0.92%-15.49%+9.17% 7.56B
Average +1.28%+0.78%+29.21%+25.52% 21.84B
Weighted average by Cap. +1.50%+2.56%+25.00%+34.21%

Financials

2027 *2028 *
Net sales 3,281B 20.73B 18.42B 17.26B 15.63B 29.45B 1,999B 29.71B 206B 80.39B 1,021B 77.86B 76.2B 3,373B 21.31B 18.94B 17.74B 16.07B 30.27B 2,055B 30.54B 211B 82.64B 1,049B 80.04B 78.33B
Net income 171B 1.08B 961M 901M 816M 1.54B 104B 1.55B 10.74B 4.2B 53.27B 4.06B 3.98B 185B 1.17B 1.04B 971M 880M 1.66B 113B 1.67B 11.58B 4.53B 57.46B 4.38B 4.29B
Net Debt 654B 4.13B 3.67B 3.44B 3.11B 5.87B 398B 5.92B 41B 16.02B 203B 15.52B 15.19B 579B 3.66B 3.25B 3.05B 2.76B 5.2B 353B 5.24B 36.32B 14.19B 180B 13.75B 13.45B
Projected Income Statement - Annual - Asahi Kasei Corporation
Logo Asahi Kasei Corporation
Asahi Kasei Corp is a Japan-based company mainly engaged in the materials business, housing business and healthcare business. The Company operates through three business segments. The Materials segment provides styrene monomer, acrylonitrile, polyethylene, automotive-related fibers, electronic materials, mixed signal large scale integrated circuits (LSI), hall elements, deep ultraviolet light-emitting diodes (LEDs), pharmaceutical and food additives and others. The Housing segment provides construction contracting, renovation and other housing-related business, as well as lightweight aerated concrete (ALC), insulation materials and others. The Healthcare segment provides medical drugs, hemodialysis and apheresis related equipment, virus removal filters, cardiopulmonary resuscitation-related products and others. The Company also provides plant engineering, environmental engineering, various research and information provision businesses, and personnel dispatch and introduction services.
Employees
47,895
Date Price Change Volume
06/10/26 US$21.11 +0.56% 47,120
05/10/26 US$20.99 +0.31% 30,801
02/10/26 US$20.93 +1.50% 22,589
01/10/26 US$20.62 -1.83% 29,730
30/09/26 US$21.00 +0.67% 38,281
Trader
Investor
Global
Quality
ESG MSCI
-
Ratings Surperformance© - Asahi Kasei Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
1,674.00JPY
Average target price
1,956.67JPY
Spread / Average Target
+16.89%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Asahi Kasei Corporation